Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia

Clinical Neuropharmacology

Volumn 30, Issue 4, 2007, Pages 241-244

  Alemdar, Murat ^a   Iseri, Pervin ^a   Selekler, MacIt ^a   Komsuoǧlu, Sezer Şener ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Dyskinesia; Hypoparathyroidism; Levetiracetam; Paroxysmal

Indexed keywords

ETIRACETAM; OXCARBAZEPINE; VALPROIC ACID;

ADULT; ARTICLE; BASAL GANGLION; BRAIN CALCIFICATION; BRAIN CORTEX; BRAIN STEM; CASE REPORT; CEREBELLUM; CHOREOATHETOSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DYSKINESIA; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; HYPERPARATHYROIDISM; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; THALAMUS;

ADULT; ANTICONVULSANTS; CALCINOSIS; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MOVEMENT DISORDERS; PIRACETAM;

EID: 34548411328     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/wnf.0b013e31803b9415     Document Type: Article

References (15)

1. Jankovic J, Demirkiran M. Paroxysmal dyskinesias: an update. Ann Med Sci 2001;10:92-103.
2. Rigo JM, Hans G, Nguyen L, et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 2002;136:659-672.
3. Konitsiotis S, Pappa S, Mantas C, et al. Levetiracetam in tardive dyskinesia. Mov Disord 2006;21: 1219-1221.
4. De Tommaso M, Di Fruscolo O, Sciruicchio V, et al. Efficacy of levetiracetam in Huntington disease. Clin Neuropharmacol 2005;28:280-284.
5. Chatterjee A, Louis ED, Frucht S. Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis. Mov Disord 2002;17:614-615.
6. Lance JW. Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol 1977;2:285-293.
7. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38:571-579.
8. Jarman PR, Bhatia KP, Davie C, et al. Paroxysmal dystonic choreoathetosis: clinical features and investigation of pathophysiology in a large family. Mov Disord 2000;15:648-657.
9. Soffer D, Licht A, Yaar I, et al. Paroxysmal choreoathetosis as a presenting symptom in idiopathic hypoparathyroidism. J Neurol Neurosurg Psychiatry 1977;40:692-694.
10. Yamamoto K, Kawazawa S. Basal ganglion calcification in paroxysmal dystonic choreoathetosis. Ann Neurol 1987;22:556.
11. Mink JW. The basal ganglia and involuntary movements: impaired inhibition of competing motor patterns. Arch Neurol 2003;60:1365-1368.
12. Joo EY, Hong SB, Tae WS, et al. Perfusion abnormality of the caudate nucleus in patients with paroxysmal kinesigenic choreoathetosis. Eur J Nucl Med Mol Imaging 2005;32:1205-1209.
13. Volonte MA, Perani D, Lanzi R, et al. Regression of ventral striatum hypometabolism after calcium/calcitriol therapy in paroxysmal kinesigenic choreoathetosis due to idiopathic primary hypoparathyroidism. J Neurol Neurosurg Psychiatry 2001;71:691-695.
14. Pisani A, Bonsi P, Martella G, et al. Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Epilepsia 2004;45:719-728.
15. Micheli F, Fernandez Pardal MM, Casas Parera I, et al. Sporadic paroxysmal dystonic choreoathetosis associated with basal ganglia calcifications. Ann Neurol 1986;20:750.